VivoSeq
Other

Estrogen Replacement Therapy

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Estrogen Replacement Therapy is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

33/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed4 · 67%
Terminated1 · 17%
Withdrawn1 · 17%

Clinical Trials

Trial Activity

6 trials

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 1·NCT00318318·20 enrolled
POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease
Completed·TThe Parkinson Study Group·Phase 2·NCT00234676·23 enrolled
Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
Completed·National Institute of Dental and Craniofacial Research (NIDCR)·Phase 3·NCT00004650·150 enrolled
Perimenopausal Estrogen Replacement Therapy Study
Completed·UUniversity of North Carolina, Chapel Hill·Phase 2/3·NCT01308814·172 enrolled
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Terminated·UUniversity of Chicago·Phase 2·NCT01928082·1 enrolled
Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure
Withdrawn·Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 2·NCT00370019

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)